Advertisement
Screener

Beyond Air, Inc. (XAIR) Net Income (Loss) Available to Common Stockholders, Basic

2.3 / 5 stars · 23/49 Roast Me

Beyond Air, Inc. Net Income (Loss) Available to Common Stockholders, Basic

Beyond Air, Inc. (XAIR) reported Net Income (Loss) Available to Common Stockholders, Basic of -$22.54 million for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-10.

Discontinued › Income Statement

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2021-06-10

  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-03-31 was -$4.90M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-12-31 was -$5.77M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-03-31 was -$5.27M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2019-12-31 was -$4.92M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$22.54M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for fiscal 2020 was -$20.46M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for fiscal 2019 was -$6.56M.
  • Beyond Air, Inc. net income (loss) available to common stockholders, basic for fiscal 2017 was -$18.00M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 12 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month as first filed
2021-03-31-$4.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10
-$10.67M
derived: sum of 2 quarters · filed 2021-06-10
-$22.54M
10-K · filed 2021-06-10
2020-12-31-$5.77M
10-Q · filed 2021-02-09
-$17.64M
10-Q · filed 2021-02-09
2020-03-31-$5.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10
-$10.19M
derived: sum of 2 quarters · filed 2021-06-10
-$20.46M
10-K · filed 2021-06-10
$20.46M
10-K · filed 2020-06-23
2019-12-31-$4.92M
10-Q · filed 2021-02-09
-$15.20M
10-Q · filed 2021-02-09
2019-03-31-$6.56M
10-K · filed 2020-06-23
2018-03-31$1.05M
10-KT · filed 2018-06-15
-$644.00K
derived: sum of 2 quarters · filed 2018-06-15
-$7.79M
derived: sum of 3 quarters · filed 2018-06-15
2017-12-31-$1.69M
derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15
-$8.84M
derived: sum of 2 quarters · filed 2018-06-15
-$18.00M
10-KT · filed 2018-06-15
-$18.04M
10-K · filed 2018-03-30
2017-09-30-$7.15M
10-Q · filed 2017-11-03
-$16.31M
10-Q · filed 2017-11-03
2016-12-31-$1.02M
derived: 10-KT 12 month − 10-Q 9 month · filed 2018-06-15
-$1.65M
derived: sum of 2 quarters · filed 2018-06-15
-$3.90M
10-KT · filed 2018-06-15
2016-09-30-$634.00K
10-Q · filed 2017-11-03
-$2.88M
10-Q · filed 2017-11-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B